These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21327505)

  • 21. Optimizing use of current anticoagulants.
    Witt DM
    Hematol Oncol Clin North Am; 2010 Aug; 24(4):717-26, viii. PubMed ID: 20659656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A retrospective analysis of the periprocedural management of oral anticoagulants in patients undergoing interventional radiology procedures.
    Marsh K; Ahuja T; Raco V; Green D; Sista AK; Papadopoulos J
    J Thromb Thrombolysis; 2018 Nov; 46(4):451-460. PubMed ID: 30225669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E
    Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time-driven activity-based cost analysis for outpatient anticoagulation therapy: direct costs in a primary care setting with optimal performance.
    Bobade RA; Helmers RA; Jaeger TM; Odell LJ; Haas DA; Kaplan RS
    J Med Econ; 2019 May; 22(5):471-477. PubMed ID: 30744455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of patients with thromboembolic disorders on warfarin therapy in resource limited settings.
    Kamuren Z; Kigen G; Keter A; Maritim A
    BMC Health Serv Res; 2018 Sep; 18(1):723. PubMed ID: 30231891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality control of oral anticoagulation with vitamin K antagonists in primary care patients in Poland: a multi-centre study.
    Sawicka-Powierza J; Buczkowski K; Chlabicz S; Gugnowski Z; Powierza K; Ołtarzewska AM
    Kardiol Pol; 2018; 76(4):764-769. PubMed ID: 29313558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leflunomide and warfarin interaction: case report and review of the literature.
    Chonlahan J; Halloran MA; Hammonds A
    Pharmacotherapy; 2006 Jun; 26(6):868-71. PubMed ID: 16716139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Periprocedural warfarin reversal with prothrombin complex concentrate.
    Sridharan M; Wysokinski WE; Pruthi R; Oyen L; Freeman WD; Rabinstein AA; McBane RD
    Thromb Res; 2016 Mar; 139():160-5. PubMed ID: 26657301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Problems of anticoagulation within a palliative care setting: an audit of hospice patients taking warfarin.
    Johnson MJ
    Palliat Med; 1997 Jul; 11(4):306-12. PubMed ID: 9373582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of letter communication for patients enrolled in a pharmacist managed anticoagulation clinic.
    Geyer A; Ford MA; Rindone JP
    J Clin Pharm Ther; 2011 Oct; 36(5):553-6. PubMed ID: 21916907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of INR monitoring, reversal agent use, heparin bridging, and anticoagulant interruption on rebleeding and thromboembolism in acute gastrointestinal bleeding.
    Nagata N; Sakurai T; Moriyasu S; Shimbo T; Okubo H; Watanabe K; Yokoi C; Yanase M; Akiyama J; Uemura N
    PLoS One; 2017; 12(9):e0183423. PubMed ID: 28863196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial.
    Wallentin L; Yusuf S; Ezekowitz MD; Alings M; Flather M; Franzosi MG; Pais P; Dans A; Eikelboom J; Oldgren J; Pogue J; Reilly PA; Yang S; Connolly SJ;
    Lancet; 2010 Sep; 376(9745):975-83. PubMed ID: 20801496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of anticoagulation provider continuity on time in therapeutic range for warfarin patients.
    Bishop MA; Streiff MB
    J Thromb Thrombolysis; 2016 Aug; 42(2):283-7. PubMed ID: 27085542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonadherence with INR monitoring and anticoagulant complications.
    Witt DM; Delate T; Clark NP; Garcia DA; Hylek EM; Ageno W; Dentali F; Crowther MA
    Thromb Res; 2013 Aug; 132(2):e124-30. PubMed ID: 23800635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management.
    Phillips KW; Ansell J
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):57-70. PubMed ID: 18095907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Majority of Total Joint Arthroplasties Are Subtherapeutic on Warfarin at Time of Discharge: Another Reason to Avoid Warfarin as a Venous Thromboembolism Prophylaxis?
    Rondon AJ; Goswami K; Tan TL; Shohat N; Parvizi J
    J Arthroplasty; 2018 Sep; 33(9):2787-2791. PubMed ID: 29871833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Near-patient testing devices to monitor oral anticoagulant therapy.
    Tripodi A; Chantarangkul V; Mannucci P
    Br J Haematol; 2001 Jun; 113(4):847-52. PubMed ID: 11442473
    [No Abstract]   [Full Text] [Related]  

  • 39. Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trial.
    Onundarson PT; Francis CW; Indridason OS; Arnar DO; Bjornsson ES; Magnusson MK; Juliusson SJ; Jensdottir HM; Vidarsson B; Gunnarsson PS; Lund SH; Gudmundsdottir BR
    Lancet Haematol; 2015 Jun; 2(6):e231-40. PubMed ID: 26688233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence of nontherapeutic and dangerous international normalized ratios among patients receiving warfarin in the emergency department.
    Newman DH; Zhitomirsky I
    Ann Emerg Med; 2006 Aug; 48(2):182-9, 189.e1. PubMed ID: 16953531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.